MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/annrheumdis-2019-215787

Медицинская библиотека · Annals of the rheumatic diseases · 2019

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual.

Fasano Serena, Riccardi Antonella, Messiniti Valentina, Caramaschi Paola, Rosato Edoardo, Maurer Britta, Smith Vanessa, Siegert Elise, De Langhe Ellen, Riccieri Valeria, Airó Paolo, Mihai Carina, Avouac Jerome, Zanatta Elisabetta, Walker Ulrich A, Iannone Florenzo, García De la Peña Lefebvre Paloma, Distler Jörg H W, Vacca Alessandra, Distler Oliver, Kowal-Bielecka Otylia, Allanore Yannick, Valentini Gabriele

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The European Scleroderma Trials and Research Group (EUSTAR) recently developed a preliminarily revised activity index (AI) that performed better than the European Scleroderma Study Group Activity Index (EScSG-AI) in systemic sclerosis (SSc).

OBJECTIVE

To assess the predictive value for short-term disease severity accrual of the EUSTAR-AI, as compared with those of the EScSG-AI and of known adverse prognostic factors.

METHODS

Patients with SSc from the EUSTAR database with a disease duration from the onset of the first non-Raynaud sign/symptom ≤5 years and a baseline visit between 2003 and 2014 were first extracted. To capture the disease activity variations over time, EUSTAR-AI and EScSG-AI adjusted means were calculated. The primary outcome was disease progression defined as a Δ≥1 in the Medsger's severity score and in distinct items at the 2-year follow-up visit. Logistic regression analysis was carried out to identify predictive factors.

RESULTS

549 patients were enrolled. At multivariate analysis, the EUSTAR-AI adjusted mean was the only predictor of any severity accrual and of that of lung and heart, skin and peripheral vascular disease over 2 years.

CONCLUSION

The adjusted mean EUSTAR-AI has the best predictive value for disease progression and development of severe organ involvement over time in SSc.

Для цитирования: Fasano Serena, Riccardi Antonella, Messiniti Valentina, Caramaschi Paola, Rosato Edoardo, Maurer Britta, Smith Vanessa, Siegert Elise, De Langhe Ellen, Riccieri Valeria, Airó Paolo, Mihai Carina, Avouac Jerome, Zanatta Elisabetta, Walker Ulrich A, Iannone Florenzo, García De la Peña Lefebvre Paloma, Distler Jörg H W, Vacca Alessandra, Distler Oliver, Kowal-Bielecka Otylia, Allanore Yannick, Valentini Gabriele. Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual.. Annals of the rheumatic diseases. 2019. DOI: 10.1136/annrheumdis-2019-215787.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.